Publications by authors named "Musa Sahpolat"

Background: Nesfatin-1 (NF-1) is a parameter that has been shown to have an important potential in the modulation of the emotional state such as depression. The study focused to investigate the relationship between the plasma NF-1 level and depression.

Subjects And Methods: Seventy-three patients who have a major depressive disorder (MDD) and 71 healthy individuals participated in the study.

View Article and Find Full Text PDF

Objective: This study was conducted to determine the effect of the level of solution-focused thinking on internalized stigma and social functionality in mental illnesses.

Design And Methods: This descriptive study was conducted with 497 patients with various mental disorders.

Findings: A negative and strong correlation was found between the Solution-Focused Inventory and Internalized Stigma of Mental Illness Scale scores of the participants (r = -0.

View Article and Find Full Text PDF

Objective: Monocyte to high density lipoprotein ratio (MHR) is a new instrument for giving notice inflammation, which plays a main role in schizophrenia. Thus, in this study, our goal was to investigate the possible association between MHR and schizophrenia.

Methods: The participants of this study consisted of 75 schizophrenia patients and 74 healthy individuals (control group).

View Article and Find Full Text PDF

Background: Schizophrenia patients (SPP) have an increased risk of metabolic syndrome (MetS) and are twice more likely to experience diabetes mellitus and obesity than the general population.

Aims: The main purpose of this study was to assess the prevalence of MetS and its components in first-episode psychosis patients (FEPP) and SPP.

Methods: This study consisted a total of 38 untreated FEPP, 40 SPP and 41 randomly selected healthy volunteers admitted to the psychiatric outpatient clinic.

View Article and Find Full Text PDF

Objective: This study aims to investigate the possible relationship between plasma concentrations of apelin, visfatin and resistin levels of first episode psychosis patients and chronic schizophrenia patients.

Methods: A total number of 29 untreated patients with first episode psychosis, 30 chronic schizophrenia and 29 randomly selected weight- and body mass index-matched healthy volunteers were included. The Diagnostic and Statistical Manual of Mental Disorders 4th edition, Positive and Negative Syndrome Scale (PANSS) and Clinical Global Impression Scale were applied to the patient groups.

View Article and Find Full Text PDF

Objective: The relationship between platelet activation and psychiatric disorders has been shown in previous work. Mean platelet volume (MPV) is a measure of platelet size and a good indicator of platelet activity, which increases in cardiovascular diseases (CVDs). It is known that anxiety is a considerable factor in the etiology of mortality in CVDs.

View Article and Find Full Text PDF

Paliperidone which is the active metabolite of risperidon is one of the novel antipsychotics. Controlled clinical studies proved its effectiveness on decreasing the positive and negative symptoms of schizophrenia. Some studies and case reports, reported its cardiovascular and cardiometabolic side effects.

View Article and Find Full Text PDF